Active Product Ingredients (API) Manufacturing

FDA Inspected
Drug Master File Preparation & Maintenance
Active Product Ingredients (API) Process Development: Exclusive, Proprietary & Non-Proprietary
Cyto-toxic Compound Handling Capabilities
10 Type II DMFs
High Potency Containment Suite
Multistep Organic Production
Specializing in Nucleoside Therapeutics
Complete Analytical Support
Assay Validation & Stability Studies
Reference Standards
Process Validation
Confidentiality & Exclusive Production Agressment
5-200 L Reaction vessels; 300 L resin columns; 80L, 40L, 20L SiO2 columns